Roundup Cancer Lawsuit 2026: Claims, Payouts & Deadlines

Quick Answer Box

• What this case is: A mass tort against Bayer AG (former Monsanto) alleging Roundup's active ingredient, glyphosate, causes non-Hodgkin lymphoma without adequate consumer warning.
• Who qualifies: Individuals diagnosed with non-Hodgkin lymphoma or a related blood cancer after documented exposure to Roundup weed killer, typically over multiple years.
• What it's worth: Individual settlements have ranged from $5,000 to over $250,000, with larger awards reaching into the millions in jury verdicts; payouts depend on exposure duration, cancer severity, and case venue.

Case Snapshot

The Roundup Cancer Lawsuit: What This Case Is and Why It Still Matters

The Roundup cancer lawsuit is one of the largest product liability litigations in U.S. history. It targets Bayer AG, the German pharmaceutical company that acquired Monsanto in 2018, over allegations that Roundup's primary active ingredient, glyphosate, causes non-Hodgkin lymphoma.

The central legal theory is not that Bayer manufactured a defective chemical. The theory is that Monsanto knew about the cancer risk, suppressed internal research, and sold the product for decades without a meaningful warning label.

Also worth exploring: Taylor Swift Lawsuit 2026: Cases, Claims & Payouts

Since 2018, juries have returned verdicts exceeding $2 billion in individual cases before judicial reductions. The litigation shows no sign of final resolution in 2026.

*Attorney Insight: Attorneys handling these claims consistently identify the failure-to-warn theory as the strongest angle, because it does not require proving the product was inherently defective, only that the manufacturer knew of the risk and said nothing.*

Key case facts at a glance:

• Glyphosate was classified as "probably carcinogenic to humans" by the International Agency for Research on Cancer (IARC) in March 2015
• Monsanto was acquired by Bayer for $63 billion in June 2018
• The first federal MDL bellwether case was tried in 2019
• Bayer announced a $10.9 billion settlement framework in June 2020

Roundup Lawsuit Update 2026: Where the Case Stands Now

As of 2026, the Roundup litigation remains one of the most active mass torts in the federal court system. Bayer's 2020 settlement framework resolved tens of thousands of existing claims, but it did not close the litigation.

The company's attempt to cap future liability through a proposed Supreme Court review failed to gain traction. That means newly diagnosed claimants, and those who did not participate in earlier settlement waves, are still pursuing individual claims in both state and federal courts.

Bayer has publicly stated its intention to continue defending cases rather than agree to a blanket resolution for all future plaintiffs. That posture has kept trial dockets active in California, Missouri, and other jurisdictions.

2026 Litigation Status Summary:

*Attorney Insight: Attorneys handling these claims note that Bayer's decision to litigate rather than settle all remaining cases creates real trial risk, but also real settlement leverage for claimants with strong medical and exposure documentation.*

Litigation Watch: The Roundup litigation is active in 2026, the global settlement did not terminate new claims, and Bayer continues to face trial exposure in multiple state jurisdictions.

Does Roundup Cause Cancer? What the Lawsuit Alleges

The roundup causes cancer lawsuit rests on a specific factual and scientific claim: that glyphosate, the herbicide's active ingredient, is a probable human carcinogen. Plaintiffs do not need to prove this to a scientific certainty in court. They need to show that the evidence was strong enough that Monsanto had a duty to warn.

The IARC's March 2015 classification of glyphosate as "Group 2A: Probably Carcinogenic to Humans" became the anchor of that argument. Internal Monsanto documents produced during discovery showed that company scientists were aware of concerning data years before any public disclosure.

The U.S. EPA has maintained a different position, classifying glyphosate as "not likely to be carcinogenic." That regulatory disagreement has been a recurring issue in trial proceedings, with courts deciding case-by-case whether EPA's label approvals preempt state law failure-to-warn claims.

*Attorney Insight: Attorneys handling these claims point to the internal Monsanto communications revealed in discovery, sometimes called the "Monsanto Papers," as the evidentiary backbone that has driven multiple eight-figure jury verdicts.*

Scientific and Regulatory Positions:

Roundup Weed Killer Cancer Lawsuit: The History Behind the Case

The roundup weed killer cancer lawsuit did not emerge from a single incident. It built over decades of scientific scrutiny and corporate litigation strategy.

Monsanto introduced Roundup in 1974. The herbicide became the world's most widely used weed killer, sold in more than 160 countries. Residential use surged after the introduction of Roundup Ready genetically modified crops in the 1990s, because farmers could spray entire fields without harming their crops.

The first major plaintiff victory came in August 2018, when a California jury awarded $289 million to school groundskeeper Dewayne Johnson, who had been diagnosed with non-Hodgkin lymphoma after years of Roundup exposure. That verdict was later reduced to $78.5 million but upheld on appeal.

Two subsequent California verdicts, both in 2019, awarded $80 million and $2 billion respectively, the latter later reduced to $87 million by the trial judge.

*Attorney Insight: Attorneys handling these claims note that the early California verdicts, though later reduced, established the evidentiary framework and jury persuasion arc that all subsequent Roundup trials have built on.*

Major Trial Verdicts (Pre-Settlement):

Roundup Glyphosate Cancer Lawsuit: The Science Courts Have Accepted

The roundup glyphosate cancer lawsuit turns on whether glyphosate exposure can be causally linked to a specific plaintiff's cancer diagnosis. Federal courts have allowed expert testimony on causation to proceed under the Daubert standard, meaning the science underlying these claims has survived repeated legal challenges.

Epidemiological studies, including a large 2019 meta-analysis published in the journal *Mutation Research*, found a 41% increased risk of non-Hodgkin lymphoma among individuals with high glyphosate exposure. That figure has been cited in multiple trial records.

Monsanto challenged plaintiff expert testimony at the Daubert stage in MDL 2741. Judge Chhabria allowed the testimony to proceed in a March 2019 ruling, a decision that opened the MDL to full bellwether trials and effectively set the litigation on its current course.

*Attorney Insight: Attorneys handling these claims identify Judge Chhabria's Daubert ruling as the single most consequential procedural decision in the litigation, because it validated the causal science framework that plaintiffs rely on in every trial.*

Litigation Watch: Glyphosate causation science has cleared the Daubert threshold in federal court, meaning plaintiffs' expert testimony on cancer risk is legally admissible, which is a foundational requirement for these cases to go to trial.

Roundup MDL 2741: How Federal Consolidation Shaped the Litigation

MDL 2741, formally titled *In re: Roundup Products Liability Litigation*, is the federal multidistrict litigation consolidating all federal Roundup cases before Judge Vince Chhabria in the Northern District of California.

MDL consolidation does not mean a class action. Each plaintiff retains an individual case. The MDL process centralizes pretrial discovery, expert witness hearings, and early procedural motions to avoid redundant proceedings across hundreds of federal courts.

The MDL was established by the Judicial Panel on Multidistrict Litigation on October 3, 2016. By 2020, it contained more than 125,000 registered plaintiffs. Even after the settlement framework was announced, thousands of cases remained pending or were added by newly diagnosed claimants.

*Attorney Insight: Attorneys handling these claims explain that the MDL structure means a plaintiff's case is managed centrally for pretrial purposes but can be remanded to their home district for trial, which affects venue strategy and potential jury pools.*

MDL 2741 Key Dates:

Roundup Non-Hodgkin Lymphoma Lawsuit: The Primary Qualifying Cancer

Non-Hodgkin lymphoma is the cancer most consistently linked to glyphosate exposure in both the scientific literature and court records, making it the primary qualifying diagnosis in the roundup non-Hodgkin lymphoma lawsuit.

Non-Hodgkin lymphoma (NHL) is a group of blood cancers that develop in the lymphatic system. It is not a single disease. There are more than 60 distinct subtypes. Courts and settlement administrators have recognized specific subtypes as having the strongest glyphosate association.

Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma are the subtypes most frequently cited in Roundup plaintiff medical records and expert testimony. Both are B-cell lymphomas, consistent with the biological mechanism proposed in the IARC classification.

*Attorney Insight: Attorneys handling these claims indicate that the strength of a plaintiff's causation argument often depends on which subtype of NHL they were diagnosed with, because some subtypes have a stronger documented association with glyphosate than others.*

Non-Hodgkin Lymphoma Subtypes Associated with Roundup Claims:

What Type of Cancer Qualifies for the Roundup Lawsuit?

The Roundup lawsuit primarily covers non-Hodgkin lymphoma diagnoses, but the qualifying cancer list is not limited to a single diagnosis. Settlement administrators and plaintiff attorneys have accepted a defined range of lymphatic and blood cancers for evaluation.

NHL subtypes remain the strongest-supported claims, based on the existing epidemiological record. Some plaintiffs with Hodgkin lymphoma diagnoses have filed claims, though these are evaluated individually and the scientific association is less robust.

Leukemia claims have been filed in smaller numbers. B-cell chronic lymphocytic leukemia (B-CLL) has appeared in some plaintiff records, and some oncologists consider it on the NHL spectrum. Those cases receive individualized causation analysis.

*Attorney Insight: Attorneys handling these claims advise that a diagnosis outside the core NHL category does not automatically disqualify a claimant, but it does require a stronger individual causation argument supported by medical expert testimony.*

Cancer Diagnoses and Claim Viability:

Litigation Watch: Non-Hodgkin lymphoma remains the anchor diagnosis for Roundup claims in 2026, and plaintiffs with DLBCL or follicular lymphoma diagnoses carry the strongest evidentiary foundation for compensation.

Who Qualifies for the Roundup Lawsuit in 2026?

Qualification for a Roundup cancer claim in 2026 depends on three factors: a confirmed cancer diagnosis, documented Roundup exposure, and a claim filed within the applicable statute of limitations.

The exposure requirement is not limited to occupational use. Residential users, including homeowners who applied Roundup in their yards, gardens, or on driveways over multiple years, have qualified and received compensation.

The diagnostic requirement focuses on NHL and related blood cancers. The exposure timeline matters. Most attorneys seek plaintiffs who used Roundup for at least two years and were diagnosed with cancer after that documented use period.

*Attorney Insight: Attorneys handling these claims report that the most common disqualifying factor they encounter is not the cancer diagnosis, but the inability to document consistent Roundup use over a sufficient period, which underscores the importance of gathering purchase records, photographs, or witness statements early.*

Explore this too: AT&T Data Breach Lawsuit: Sign Up & Claim Guide 2026

Roundup Claim Qualification Checklist:

• Diagnosed with non-Hodgkin lymphoma or a qualifying blood cancer
• Documented exposure to Roundup or glyphosate-based herbicide
• Exposure lasted at least two years (residential or occupational)
• Diagnosis occurred after the primary period of Roundup use
• Claim filed within the applicable state statute of limitations
• No prior settlement or release of Roundup claims against Bayer/Monsanto

Roundup Lawsuit Eligibility Requirements: A Closer Look

The roundup lawsuit eligibility requirements go beyond a simple checklist. Claims administrators and plaintiff attorneys apply a more granular evaluation when assessing whether a claim has sufficient value to proceed.

Exposure frequency matters alongside duration. A plaintiff who sprayed Roundup weekly for five years presents a stronger exposure argument than someone who used it twice a year over a similar period. Courts have examined this distinction in expert testimony on dose-response relationships.

Age at diagnosis, cancer stage, treatment history, and whether the plaintiff is still living all affect both eligibility thresholds and potential compensation. Wrongful death claims, filed by surviving family members, follow slightly different procedural rules depending on state law.

*Attorney Insight: Attorneys handling these claims note that claims with occupational exposure histories, such as farm workers, landscapers, groundskeepers, and golf course employees, tend to receive higher tier compensation offers because exposure documentation is easier to establish and exposure levels were typically higher.*

Eligibility Evaluation Factors:

Roundup Lawsuit Settlement Amounts 2026: What the Numbers Show

Roundup lawsuit settlement amounts in 2026 reflect a tiered compensation structure that Bayer developed as part of its $10.9 billion settlement framework announced in June 2020. That framework divided claimants into severity categories.

The settlement amounts are not uniform. They range from approximately $5,000 for lower-tier claims, typically older cases with limited documentation or less severe diagnoses, to $250,000 or more for high-tier cases involving severe NHL diagnoses, strong exposure records, and significant medical expenses.

Jury verdicts in cases that went to trial have reached substantially higher figures before judicial reduction. The Pilliod verdict of $2.055 billion, though reduced to $87 million, illustrates the ceiling that trial outcomes can theoretically reach.

*Attorney Insight: Attorneys handling these claims explain that the gap between settlement offers and potential jury verdicts is why some plaintiffs reject settlement tier offers and pursue trial, though that strategy carries significant time and risk.*

Roundup Settlement Tier Estimates (2026):

Litigation Watch: Settlement amounts in 2026 remain tiered based on diagnosis severity and exposure documentation, and plaintiffs with strong evidence profiles consistently receive higher offers than those filing with incomplete records.

Bayer Roundup Settlement 2026: What Bayer Has Agreed To and What Remains Open

The Bayer Roundup settlement announced in June 2020 committed approximately $10.9 billion to resolve existing claims. Of that, roughly $8.8 billion to $9.6 billion was allocated to settling claims from approximately 95,000 plaintiffs who had already filed.

The remaining portion was set aside for future claimants. That future claimant fund has been a source of ongoing litigation, because Bayer sought to use it to cap liability for people diagnosed after the settlement date. Courts have not granted Bayer the sweeping liability shield it sought.

As of 2026, Bayer continues to resolve individual cases through negotiated settlements while simultaneously defending cases at trial. The company has not announced a new global settlement framework to replace the 2020 agreement.

*Attorney Insight: Attorneys handling these claims indicate that Bayer's current posture, settling selectively while going to trial in some cases, creates a mixed outcome environment where case-by-case litigation strategy has a larger impact on compensation than at the height of the global settlement process.*

Bayer Settlement Framework: Key Financial Figures

Roundup Lawsuit Payout Per Person: How Individual Compensation Is Calculated

The roundup lawsuit payout per person is not a fixed figure. It is calculated through a formula that weighs multiple plaintiff-specific variables rather than applying a single standard amount.

Compensatory damages cover documented financial losses: medical expenses, lost income, future treatment costs, and pain and suffering. Punitive damages, awarded only at trial and at the jury's discretion, are intended to punish Bayer for conduct the jury finds reprehensible.

Most settling plaintiffs receive compensatory damages only. Trial plaintiffs who win can receive both, though courts have repeatedly reduced punitive awards under constitutional due-process limits that cap punitive damages at ratios relative to compensatory awards.

*Attorney Insight: Attorneys handling these claims note that the expected value calculation, weighing a certain settlement against the uncertain but potentially higher trial outcome, drives most individual case strategy decisions, and that calculation differs significantly based on the strength of each client's exposure evidence.*

Individual Payout Calculation Factors:

• Total documented medical expenses
• Lost wages and future earning capacity
• Pain and suffering valuation (varies by state law)
• Cancer severity and prognosis
• Life expectancy impact
• Strength of exposure documentation
• Whether punitive damages are sought at trial

Roundup Weed Killer Lawsuit Compensation: Who Has Received the Most

Roundup weed killer lawsuit compensation at its highest has come from jury verdicts in cases where plaintiffs presented overwhelming exposure evidence and compelling cancer timelines.

The three original California bellwether verdicts, Johnson, Hardeman, and Pilliod, produced the most publicly documented compensation outcomes. Each involved plaintiffs with years of direct Roundup application and NHL diagnoses that treating physicians linked to that exposure.

In the Pilliod case, a California jury awarded the couple $2.055 billion in January 2019, reduced to $87 million by the trial judge. Alva and Alberta Pilliod had used Roundup for decades. Both were diagnosed with non-Hodgkin lymphoma.

*Attorney Insight: Attorneys handling these claims point out that the size of those early verdicts was not accidental; plaintiffs' teams introduced internal Monsanto documents that showed executive awareness of cancer risk paired with deliberate efforts to undermine independent research, a combination that consistently inflames jury sentiment.*

Highest Documented Roundup Compensation Outcomes:

Roundup Lawsuit Filing Deadline 2026: When You Must Act

The roundup lawsuit filing deadline in 2026 is governed by state-specific statutes of limitations, not a single national deadline. This is the most consequential timing issue for any new claimant.

Most states allow two to three years from the date of diagnosis, or from the date a plaintiff reasonably discovered the connection between Roundup and their cancer, to file a claim. The "discovery rule" is critical: it can extend the filing window for plaintiffs who were diagnosed years ago but only recently learned about the Roundup litigation.

Missing the statute of limitations deadline is fatal to a claim. Courts have dismissed otherwise meritorious cases solely because the plaintiff filed one day too late. There is no administrative grace period in civil litigation.

*Attorney Insight: Attorneys handling these claims consistently advise that the safest approach is to treat the diagnosis date as the start of the limitations clock, even if the discovery rule might theoretically extend it, because relying on discovery rule tolling is a litigation risk that can be avoided by filing promptly.*

State Statute of Limitations: Selected Examples

Roundup Lawsuit Statute of Limitations: State-by-State Considerations

The roundup lawsuit statute of limitations is the legal deadline by which a claim must be filed in court. It operates differently from a claims registration form or an attorney intake consultation.

Consulting an attorney does not toll the statute of limitations. Filing a lawsuit does. This distinction has caused serious consequences for Roundup plaintiffs who believed that signing a retainer agreement or completing an online intake form protected their rights.

You may want to read Meta Lawsuit 2026: Cases, Settlements & Your Rights

Some states have enacted specific discovery rules that begin the clock from the date a plaintiff knew, or reasonably should have known, that their cancer was linked to a specific product. In Roundup cases, courts have been asked to determine when the IARC's 2015 classification became sufficient public knowledge to trigger that constructive discovery.

*Attorney Insight: Attorneys handling these claims flag Missouri as a particularly favorable jurisdiction because its five-year limitations period gives plaintiffs more time to develop strong medical and exposure documentation before filing, without sacrificing their legal rights.*

Litigation Watch: The statute of limitations is a hard cutoff with no consumer-protection exceptions, and any Roundup claimant who has not formally filed in court should contact a mass tort attorney before the deadline passes.

How to File a Roundup Cancer Claim: The Process in 2026

Filing a Roundup cancer claim in 2026 follows a defined sequence that begins with attorney retention and ends with either settlement or trial. The process is not self-service.

Roundup cases are handled by attorneys on a contingency fee basis. Plaintiffs pay no upfront legal fees. The attorney collects a percentage, typically 33% to 40%, only if the case resolves with compensation. This structure is standard in mass tort litigation.

After retaining an attorney, the claim intake process involves gathering medical records confirming the cancer diagnosis, documentation of Roundup purchase and use history, and any employment records supporting occupational exposure. The attorney then files the individual complaint, either directly in the MDL or in the appropriate state court.

*Attorney Insight: Attorneys handling these claims note that the documentation phase is where cases are won or lost before they ever reach a courtroom, and that plaintiffs who can produce purchase receipts, photographs of product use, or contemporaneous records of exposure timing consistently receive higher settlement valuations.*

Roundup Claim Filing Sequence:

1. Retain a mass tort or product liability attorney
2. Provide medical records confirming qualifying cancer diagnosis
3. Document Roundup exposure history (purchase records, employment records, photographs)
4. Attorney files individual complaint in federal MDL or appropriate state court
5. Case enters discovery or settlement evaluation process
6. Plaintiff receives settlement offer or case proceeds toward trial
7. Settlement accepted or trial verdict rendered

Roundup Lawsuit Cancer: The Broader Impact on Plaintiffs and the Legal System

The roundup lawsuit cancer litigation has reshaped product liability law in ways that extend beyond glyphosate. It established that internal corporate documents showing knowledge of risk, when contrasted with public denial, can overcome regulatory approval as a defense.

The EPA's continued approval of glyphosate labels without cancer warnings became a central defense argument in every Roundup trial. Courts ruled that federal label approval does not automatically preempt state law failure-to-warn claims. That ruling preserved the legal rights of more than 160,000 registered plaintiffs.

The litigation has also placed public health implications squarely on record in federal court. Studies entered into evidence have documented glyphosate residue in human urine samples, food products, and drinking water sources, a factual record that now exists independently of regulatory agency positions.

*Attorney Insight: Attorneys handling these claims point to the federal preemption rulings as the legal contribution of the Roundup litigation that will most influence future pesticide and herbicide product liability cases, because it established that EPA label approval is not a complete immunity shield for manufacturers.*

Roundup Litigation's Broader Legal Impact:

• Federal preemption argument rejected in multiple circuit courts
• Internal corporate document discovery set precedent for similar agricultural chemical cases
• IARC Group 2A classification established as trial-admissible scientific foundation
• MDL 2741 structure influenced how subsequent agricultural chemical MDLs were organized
• State court venues, particularly California and Missouri, emerged as plaintiff-favorable forums

Frequently Asked Questions

What cancer does Roundup cause that qualifies for the lawsuit?

Non-Hodgkin lymphoma is the primary qualifying diagnosis for the Roundup cancer lawsuit.

Diffuse large B-cell lymphoma and follicular lymphoma are the most commonly accepted subtypes, based on epidemiological evidence cited in federal court proceedings.

Some B-cell chronic lymphocytic leukemia cases have also been evaluated, though the scientific association is less established.

How much is the average Roundup lawsuit settlement payout per person?

The average Roundup settlement payout has ranged from approximately $5,000 to $250,000, depending on the severity of the cancer diagnosis, the strength of exposure documentation, and whether the case was resolved through the settlement framework or individual negotiation.

Trial verdicts have reached significantly higher figures before judicial reduction.

No single average applies uniformly, because compensation is calculated on individual case factors.

Who qualifies for the Roundup cancer lawsuit in 2026?

To qualify in 2026, a claimant must have a confirmed diagnosis of non-Hodgkin lymphoma or a related qualifying blood cancer, documented exposure to Roundup over a meaningful period, and a claim filed within the applicable state statute of limitations.

Residential users as well as occupational users have successfully qualified.

Claims must not have been previously released through a prior Roundup settlement agreement.

What is the filing deadline for the Roundup weed killer cancer lawsuit?

There is no single national filing deadline. Each state's statute of limitations governs, and most states allow two to three years from the date of diagnosis or discovery of the Roundup connection.

Missouri provides a more favorable five-year window.

Missing the deadline terminates a claim permanently, regardless of its merit.

How do I file a Roundup cancer claim and what documents do I need?

Filing a Roundup cancer claim requires retaining a mass tort or product liability attorney, who handles the actual court filing.

Key documents include medical records confirming the cancer diagnosis, records documenting Roundup purchase and application history, and any employment records supporting occupational exposure claims.

Attorneys work on contingency, meaning no upfront fees are required.

Is the Roundup lawsuit still active in 2026 or has it been settled?

The Roundup lawsuit is still active in 2026. Bayer's 2020 settlement framework resolved approximately 95,000 existing claims but did not close the litigation to new claimants.

State and federal cases continue to be filed, and Bayer is defending some cases at trial rather than settling them.

New claimants diagnosed after 2020 can still pursue compensation if they meet eligibility requirements and file within the applicable time limit.

What Comes Next for Roundup Plaintiffs in 2026

The Roundup cancer lawsuit is not a historical case waiting for a final chapter. It is active litigation with real deadlines and real consequences for people diagnosed with non-Hodgkin lymphoma who have not yet taken legal action.

Bayer's willingness to defend individual cases at trial rather than agree to universal settlement terms means that the quality of legal representation and the strength of each claimant's documentation directly affect outcome. This is not litigation where passive waiting produces results.

If you have been diagnosed with non-Hodgkin lymphoma and have a history of Roundup exposure, consulting with an attorney who specifically handles mass tort or product liability cases is the concrete next step. The statute of limitations does not pause during the decision-making process.

A closely related topic: Apple Watch Lawsuit 2026: Claims, Payouts, Updates